Why the study?
Patients with pulmonary arterial hypertension have exceptionally high perioperative risk.
Answers are grounded in this paper and cite their sources.
This review highlights the role of inflammation as a driver of disease pathogenesis and a potential therapeutic target in pulmonary arterial hypertension.
Patients with pulmonary arterial hypertension have exceptionally high perioperative risk. This review summarizes the clinical presentation and therapies for PAH, and highlights evidence for inflammation as a driver of disease pathogenesis and a therapeutic target.
No takes yet. Share an insight, caveat, or question.
Goldenberg et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: